Onward Medical N.V.
ONWRF
$4.60
-$0.39-7.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.88M | 853.20K | -203.90K | 189.30K | 574.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.88M | 853.20K | -203.90K | 189.30K | 574.00K |
| Cost of Revenue | 15.04M | 14.83M | 14.54M | 15.62M | 16.60M |
| Gross Profit | -13.16M | -13.98M | -14.75M | -15.43M | -16.02M |
| SG&A Expenses | 19.39M | 18.60M | 17.71M | 17.42M | 17.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.57M | 38.95M | 38.12M | 38.65M | 38.92M |
| Operating Income | -37.69M | -38.09M | -38.33M | -38.46M | -38.35M |
| Income Before Tax | -38.69M | -38.59M | -38.30M | -38.78M | -39.01M |
| Income Tax Expenses | -42.70K | -157.50K | -276.60K | -81.00K | 115.70K |
| Earnings from Continuing Operations | -38.65 | -38.43 | -38.02 | -38.69 | -39.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.65M | -38.43M | -38.02M | -38.69M | -39.13M |
| EBIT | -37.69M | -38.09M | -38.33M | -38.46M | -38.35M |
| EBITDA | -36.99M | -37.42M | -37.69M | -37.88M | -37.83M |
| EPS Basic | -0.92 | -1.05 | -1.17 | -1.24 | -1.30 |
| Normalized Basic EPS | -0.58 | -0.66 | -0.74 | -0.78 | -0.81 |
| EPS Diluted | -0.92 | -1.05 | -1.18 | -1.24 | -1.30 |
| Normalized Diluted EPS | -0.58 | -0.66 | -0.74 | -0.78 | -0.81 |
| Average Basic Shares Outstanding | 178.52M | 154.12M | 129.73M | 125.23M | 120.74M |
| Average Diluted Shares Outstanding | 178.52M | 154.12M | 129.73M | 125.23M | 120.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |